Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	tRNA binding	SLFN12L NEMF SSB RPL6	1.11e-04	87	57	4	GO:0000049
GeneOntologyCellularComponent	lateral plasma membrane	DSG2 APC MARK2 IQGAP1	1.14e-04	90	58	4	GO:0016328
GeneOntologyCellularComponent	cytosolic ribosome	RPL22 RPL7L1 NEMF RPL6	3.91e-04	124	58	4	GO:0022626
GeneOntologyCellularComponent	cytosolic large ribosomal subunit	RPL22 RPL7L1 RPL6	5.90e-04	59	58	3	GO:0022625
GeneOntologyCellularComponent	ribosome	RPL22 RPL7L1 NEMF NUFIP2 RPL6	8.64e-04	267	58	5	GO:0005840
GeneOntologyCellularComponent	muscle myosin complex	MYH2 MYH8	8.86e-04	16	58	2	GO:0005859
Domain	Myosin-like_IQ_dom	MYH2 MYH8 IQGAP1	2.26e-05	19	55	3	IPR027401
Domain	-	MYH2 MYH8 IQGAP1	2.26e-05	19	55	3	4.10.270.10
Domain	Myosin_N	MYH2 MYH8	8.72e-04	15	55	2	PF02736
Domain	Myosin_N	MYH2 MYH8	8.72e-04	15	55	2	IPR004009
Domain	IQ	MYH2 MYH8 IQGAP1	1.20e-03	71	55	3	PF00612
Domain	Myosin_tail_1	MYH2 MYH8	1.26e-03	18	55	2	PF01576
Domain	Myosin_tail	MYH2 MYH8	1.26e-03	18	55	2	IPR002928
Domain	IQ	MYH2 MYH8 IQGAP1	1.75e-03	81	55	3	SM00015
Domain	ZnF_RBZ	DZANK1 TAF15	2.07e-03	23	55	2	SM00547
Domain	IQ_motif_EF-hand-BS	MYH2 MYH8 IQGAP1	2.37e-03	90	55	3	IPR000048
Domain	Znf_RanBP2	DZANK1 TAF15	2.45e-03	25	55	2	IPR001876
Domain	IQ	MYH2 MYH8 IQGAP1	2.60e-03	93	55	3	PS50096
Domain	Myosin_head_motor_dom	MYH2 MYH8	5.59e-03	38	55	2	IPR001609
Domain	MYOSIN_MOTOR	MYH2 MYH8	5.59e-03	38	55	2	PS51456
Domain	Myosin_head	MYH2 MYH8	5.59e-03	38	55	2	PF00063
Domain	MYSc	MYH2 MYH8	5.59e-03	38	55	2	SM00242
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	RPL22 NOLC1 RPL7L1 KAT6A NEMF NUFIP2 PUM3 SSB MARK2 LYAR DDX24 TTF1 FKBP3 RPL6 TOP2A IQGAP1	1.04e-13	759	59	16	35915203
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	RPL22 NOLC1 NUFIP2 KMT2A PUM3 TAF15 USP39 LYAR DDX24 RPL6 TOP2A IQGAP1	3.66e-10	605	59	12	28977666
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RPL22 NOLC1 RPL7L1 TRIO DSG2 NEMF PUM3 PRMT3 SSB USP39 LYAR DDX24 FKBP3 RPL6 TOP2A IQGAP1	1.20e-09	1425	59	16	30948266
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	RPL22 NOLC1 RPL7L1 NUFIP2 PUM3 SSB USP39 LYAR DDX24 RPL6 TOP2A IQGAP1	3.08e-09	731	59	12	29298432
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	DSG2 NEMF NUFIP2 KMT2A IREB2 PUM3 TAF15 SSB MARK2 LYAR CCDC77 TTF1 FKBP3 ITPA IQGAP1	6.23e-09	1371	59	15	36244648
Pubmed	The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.	RPL22 NOLC1 RPL7L1 UTP25 PUM3 MARK2 LYAR DDX24 RPL6 TOP2A	8.32e-09	483	59	10	36912080
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	RPL22 NOLC1 RPL7L1 UTP25 NUFIP2 PUM3 TAF15 USP39 LYAR DDX24 RPL6 TOP2A IQGAP1	8.87e-09	989	59	13	36424410
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	NOLC1 UTP25 NUFIP2 KMT2A PUM3 TAF15 SSB DDX24 TTF1 RPL6 IQGAP1	1.16e-08	653	59	11	22586326
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	RPL7L1 DSG2 NUFIP2 KMT2A PUM3 TAF15 SSB USP39 LYAR DDX24 RPL6 TOP2A	1.58e-08	847	59	12	35850772
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	RPL22 NOLC1 RPL7L1 DSG2 NUFIP2 PUM3 USP39 MARK2 LYAR DDX24 FKBP3 RPL6 TOP2A IQGAP1	1.76e-08	1257	59	14	36526897
Pubmed	TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence.	RPL22 NOLC1 RPL7L1 PUM3 TAF15 SSB RPL6 TOP2A IQGAP1	4.52e-08	430	59	9	38172120
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	RPL22 NOLC1 NUFIP2 PUM3 TAF15 SSB LYAR DDX24 RPL6 IQGAP1	1.44e-07	655	59	10	35819319
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	RPL7L1 UTP25 DSG2 METTL18 NUFIP2 APC KMT2A PUM3 TAF15 MARK2 LYAR TTF1 FKBP3 IQGAP1	1.52e-07	1497	59	14	31527615
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	RPL22 RPL7L1 TAF15 SSB USP39 LYAR DDX24 RPL6 TOP2A IQGAP1	3.13e-07	713	59	10	29802200
Pubmed	Beads-free protein immunoprecipitation for a mass spectrometry-based interactome and posttranslational modifications analysis.	RPL22 RPL7L1 PUM3 SSB LYAR RPL6	4.86e-07	172	59	6	26336360
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	RPL22 NOLC1 H2BC1 NUFIP2 KMT2A PUM3 TAF15 LYAR DDX24 FKBP3 TOP2A	5.25e-07	954	59	11	36373674
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	RPL22 DZANK1 HTRA1 TRIO NUFIP2 APC KMT2A TAF15 SSB MARK2 SIPA1L2 RPL6 IQGAP1	6.35e-07	1431	59	13	37142655
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	RPL22 NOLC1 RPL7L1 NUFIP2 PUM3 TAF15 SSB LYAR DDX24 TOP2A	9.63e-07	807	59	10	22681889
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	RPL22 DZANK1 APC TAF15 SSB USP39 LYAR FKBP3 RPL6 IQGAP1	9.85e-07	809	59	10	32129710
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	RPL22 NOLC1 NEMF NUFIP2 APC TAF15 SSB MARK2 DDX24 RPL6 TOP2A IQGAP1	1.01e-06	1247	59	12	27684187
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	RPL22 NOLC1 RPL7L1 DSG2 PUM3 TAF15 USP39 MARK2 RPL6 TOP2A IQGAP1	1.05e-06	1024	59	11	24711643
Pubmed	STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production.	PUM3 SSB USP39 MARK2 LYAR DDX24 RPL6	1.09e-06	316	59	7	31665637
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	TRIO NEMF NUFIP2 APC SSB USP39 FKBP3 IQGAP1	1.38e-06	475	59	8	31040226
Pubmed	ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.	NOLC1 RPL7L1 KAT6A LYAR DDX24 RPL6 TOP2A	1.45e-06	330	59	7	33301849
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	RPL22 NOLC1 NEMF APC TAF15 USP39 LYAR SIPA1L2 DDX24 FKBP3 RPL6	1.79e-06	1082	59	11	38697112
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	RPL22 NOLC1 RPL7L1 KMT2A TAF15 PRMT3 SSB LYAR DDX24 TTF1 RPL6 TOP2A	1.80e-06	1318	59	12	30463901
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	NOLC1 NUFIP2 APC MARK2 DDX24 TOP2A WDR44 IQGAP1	2.10e-06	503	59	8	16964243
Pubmed	Spatial Chromosome Folding and Active Transcription Drive DNA Fragility and Formation of Oncogenic MLL Translocations.	KMT2A TOP2A	2.83e-06	2	59	2	31202576
Pubmed	Expressions of topoisomerase IIα and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients.	ABCG2 TOP2A	2.83e-06	2	59	2	21455636
Pubmed	The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste.	UGT2A1 UGT2A2	2.83e-06	2	59	2	35039640
Pubmed	Rat olfactory bulb and epithelium UDP-glucuronosyltransferase 2A1 (UGT2A1) expression: in situ mRNA localization and quantitative analysis.	UGT2A1 UGT2A2	2.83e-06	2	59	2	11376859
Pubmed	Interaction between tumor suppressor adenomatous polyposis coli and topoisomerase IIalpha: implication for the G2/M transition.	APC TOP2A	2.83e-06	2	59	2	18632987
Pubmed	Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase.	UGT2A1 UGT2A2	2.83e-06	2	59	2	10359671
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	RPL22 RPL7L1 KMT2A TAF15 SSB LYAR FKBP3 RPL6 IQGAP1	2.99e-06	711	59	9	33022573
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	RPL22 H2BC1 NUFIP2 PUM3 SSB USP39 DDX24 RPL6 TOP2A	3.10e-06	714	59	9	28302793
Pubmed	An NAD+-Dependent Deacetylase SIRT7 Promotes HCC Development Through Deacetylation of USP39.	USP39 LYAR TOP2A	3.10e-06	17	59	3	32711345
Pubmed	Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.	RPL22 NOLC1 RPL7L1 UTP25 NUFIP2 TAF15 USP39 LYAR FKBP3	3.43e-06	723	59	9	34133714
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	NOLC1 DSG2 NUFIP2 KMT2A TAF15 SIPA1L2 FKBP3 RPL6 TOP2A WDR44	3.55e-06	934	59	10	33916271
Pubmed	Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.	RPL7L1 TAF15 SSB MARK2 LYAR SIPA1L2 RPL6 TGM5 IQGAP1	3.79e-06	732	59	9	34732716
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	RPL22 NOLC1 RPL7L1 DSG2 NUFIP2 MARK2 LYAR RPL6 TOP2A IQGAP1	4.08e-06	949	59	10	36574265
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RPL22 NOLC1 H2BC1 MYH2 MYH8 KMT2A TAF15 CCDC77 SIPA1L2 RPL6 TOP2A IQGAP1	4.53e-06	1442	59	12	35575683
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	NOLC1 SSB DDX24 TTF1 TOP2A	5.42e-06	148	59	5	32538781
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	PUM3 TAF15 USP39 MARK2 LYAR DDX24 TTF1	6.05e-06	410	59	7	26949251
Pubmed	Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.	RPL22 NOLC1 DSG2 NUFIP2 TAF15 LYAR RPL6	7.19e-06	421	59	7	34650049
Pubmed	RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.	RPL22 RPL7L1 METTL18 SSB LYAR RPL6 IQGAP1	7.64e-06	425	59	7	21081503
Pubmed	Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.	RPL22 NOLC1 DSG2 RPL6 IQGAP1	7.69e-06	159	59	5	34537242
Pubmed	Muscle Fibers Secrete FGFBP1 to Slow Degeneration of Neuromuscular Synapses during Aging and Progression of ALS.	RPL22 FGFBP1	8.48e-06	3	59	2	28053031
Pubmed	The Human UDP-glucuronosyltransferase UGT2A1 and UGT2A2 enzymes are highly active in bile acid glucuronidation.	UGT2A1 UGT2A2	8.48e-06	3	59	2	23756265
Pubmed	Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3.	UGT2A1 UGT2A2	8.48e-06	3	59	2	19858781
Pubmed	A bead-based approach for large-scale identification of in vitro kinase substrates.	SSB DDX24 RPL6 TOP2A WDR44	8.68e-06	163	59	5	22113938
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	RPL22 NOLC1 MYH2 RPL7L1 SSB USP39 MARK2 LYAR DDX24 RGS2 IQGAP1	9.14e-06	1284	59	11	17353931
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	RPL22 NEMF NUFIP2 TAF15 LYAR RPL6 TOP2A IQGAP1	9.16e-06	615	59	8	31048545
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RPL22 NOLC1 RPL7L1 KMT2A TAF15 USP39 LYAR DDX24 TTF1 RPL6 TOP2A	9.83e-06	1294	59	11	30804502
Pubmed	Activating CCT2 triggers Gli-1 activation during hypoxic condition in colorectal cancer.	NUFIP2 MARK2 RPL6	1.04e-05	25	59	3	31462707
Pubmed	LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.	RPL22 APC KMT2A MARK2 SIPA1L2 DDX24 RPL6 IQGAP1	1.21e-05	639	59	8	23443559
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	RPL22 TRIO DSG2 APC LYAR CCDC77 SIPA1L2 TOP2A IQGAP1	1.29e-05	853	59	9	28718761
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	RPL22 NOLC1 PUM3 TAF15 USP39 LYAR RPL6 TOP2A	1.40e-05	652	59	8	31180492
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	NOLC1 UTP25 DSG2 NUFIP2 USP39 LYAR TOP2A IQGAP1	1.52e-05	660	59	8	32780723
Pubmed	Evaluation of embryonic and perinatal myosin gene mutations and the etiology of congenital idiopathic clubfoot.	MYH2 MYH8	1.69e-05	4	59	2	20357587
Pubmed	Interaction with IQGAP1 links APC to Rac1, Cdc42, and actin filaments during cell polarization and migration.	APC IQGAP1	1.69e-05	4	59	2	15572129
Pubmed	Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.	KAT6A KMT2A	1.69e-05	4	59	2	23994619
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	RPL7L1 NEMF SSB USP39 DDX24 RPL6 IQGAP1	1.82e-05	486	59	7	30940648
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	KMT2A PUM3 TAF15 DDX24 TOP2A	2.06e-05	195	59	5	19454010
Pubmed	Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN.	RPL22 DSG2 TAF15 RPL6 ITPA IQGAP1	2.20e-05	334	59	6	30425250
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	NOLC1 DSG2 APC TAF15 ABCG2 SSB USP39 MARK2 TOP2A IQGAP1	2.25e-05	1155	59	10	20360068
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	RPL22 NOLC1 NEMF SSB USP39 LYAR DDX24 FKBP3 RPL6 TOP2A IQGAP1	2.26e-05	1415	59	11	28515276
Pubmed	Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion.	RPL22 NOLC1 NUFIP2 TAF15 SSB LYAR CCDC77 RPL6	2.42e-05	704	59	8	32994395
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	NOLC1 MYH2 RPL7L1 KMT2A PUM3 SSB USP39 LYAR DDX24 TOP2A IQGAP1	2.65e-05	1440	59	11	30833792
Pubmed	Directed proteomic analysis of the human nucleolus.	RPL22 PUM3 LYAR RPL6 TOP2A	2.81e-05	208	59	5	11790298
Pubmed	Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells.	KAT6A KMT2A	2.82e-05	5	59	2	20581860
Pubmed	Sequential accumulation of mRNAs encoding different myosin heavy chain isoforms during skeletal muscle development in vivo detected with a recombinant plasmid identified as coding for an adult fast myosin heavy chain from mouse skeletal muscle.	MYH2 MYH8	2.82e-05	5	59	2	6196357
Pubmed	Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily.	UGT2A1 UGT2A2	2.82e-05	5	59	2	16141793
Pubmed	IQ-domain GTPase-activating protein 1 regulates beta-catenin at membrane ruffles and its role in macropinocytosis of N-cadherin and adenomatous polyposis coli.	APC IQGAP1	2.82e-05	5	59	2	17255093
Pubmed	Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro.	MYH2 MYH8	2.82e-05	5	59	2	3829126
Pubmed	Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development.	MYH2 MYH8	2.82e-05	5	59	2	12919077
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	NOLC1 KMT2A DDX24 TOP2A	2.91e-05	103	59	4	32744500
Pubmed	Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia.	KMT2A PUM3 USP39 TOP2A	3.03e-05	104	59	4	26167872
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	RPL22 NOLC1 H2BC1 RPL6 TOP2A ITPA IQGAP1	3.47e-05	538	59	7	28524877
Pubmed	Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies.	KMT2A ABCG2 TOP2A ITPA	3.51e-05	108	59	4	19956635
Pubmed	A histone octamer-like structure within TFIID.	H2BC1 TAF15	4.23e-05	6	59	2	8598932
Pubmed	Distinct myogenic programs of embryonic and fetal mouse muscle cells: expression of the perinatal myosin heavy chain isoform in vitro.	MYH2 MYH8	4.23e-05	6	59	2	1728586
Pubmed	The ribosome quality control pathway can access nascent polypeptides stalled at the Sec61 translocon.	NEMF RPL6	4.23e-05	6	59	2	25877867
Pubmed	Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.	MYH2 MYH8	4.23e-05	6	59	2	10077619
Pubmed	Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development.	MYH2 MYH8	4.23e-05	6	59	2	10588881
Pubmed	Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics.	RPL22 SSB USP39 LYAR RPL6 IQGAP1	4.79e-05	384	59	6	31059266
Pubmed	Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication.	RPL22 LYAR RPL6 IQGAP1	5.47e-05	121	59	4	34029587
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	DSG2 APC MARK2 SIPA1L2 ITPA	5.77e-05	242	59	5	34011540
Pubmed	MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis.	KMT2A EN1	5.91e-05	7	59	2	9724755
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH2 MYH8	5.91e-05	7	59	2	35210422
Pubmed	Cloning of mouse genomic ribosomal protein L6 gene and analysis of its promoter.	RPL22 RPL6	5.91e-05	7	59	2	12031506
Pubmed	Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts.	MYH2 MYH8	5.91e-05	7	59	2	16819597
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	KAT6A KMT2A PUM3 USP39 LYAR DDX24 TOP2A	7.48e-05	608	59	7	36089195
Pubmed	Nucleolar proteome dynamics.	RPL22 PUM3 TAF15 DDX24 RPL6 TOP2A	7.75e-05	419	59	6	15635413
Pubmed	Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.	RPL7L1 NEMF PUM3 DDX24	8.14e-05	134	59	4	28695742
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RPL22 NOLC1 RPL7L1 PUM3 PRMT3 LYAR DDX24 RPL6 TOP2A IQGAP1	8.49e-05	1353	59	10	29467282
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	RPL22 NOLC1 H2BC1 MYH2 MYH8 TAF15 TOP2A IQGAP1	8.64e-05	844	59	8	25963833
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NOLC1 KMT2A PUM3 SSB USP39 FKBP3 TOP2A ITPA IQGAP1	9.49e-05	1103	59	9	34189442
Pubmed	Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation.	RPL22 MYH2 RPL6 TOP2A IQGAP1	9.83e-05	271	59	5	26816005
Pubmed	A PAK5-DNPEP-USP4 axis dictates breast cancer growth and metastasis.	TOP2A IQGAP1	1.01e-04	9	59	2	31219614
Pubmed	Transdifferentiation of esophageal smooth to skeletal muscle is myogenic bHLH factor-dependent.	MYH2 MYH8	1.01e-04	9	59	2	10725239
Interaction	RPL3 interactions	RPL22 RPL7L1 DNAJC25 METTL18 KAT6A KMT2A PUM3 SSB LYAR DDX24 TTF1 RPL6 TOP2A IQGAP1 FGFBP1	1.26e-09	722	58	15	int:RPL3
Interaction	HECTD1 interactions	RPL22 NOLC1 RPL7L1 KAT6A NEMF NUFIP2 APC PUM3 SSB MARK2 LYAR DDX24 TTF1 FKBP3 RPL6 TOP2A IQGAP1	1.32e-09	984	58	17	int:HECTD1
Interaction	RPL4 interactions	RPL22 NOLC1 RPL7L1 DNAJC25 KAT6A NUFIP2 PUM3 SSB LYAR DDX24 TTF1 RPL6 TOP2A IQGAP1 FGFBP1	2.73e-09	764	58	15	int:RPL4
Interaction	SIRT7 interactions	NOLC1 UTP25 NUFIP2 KMT2A PUM3 TAF15 SSB USP39 LYAR DDX24 TTF1 RPL6 TOP2A IQGAP1	1.74e-08	744	58	14	int:SIRT7
Interaction	RPL11 interactions	RPL22 NOLC1 RPL7L1 KAT6A NEMF NUFIP2 PUM3 SSB LYAR DDX24 TTF1 RPL6 TOP2A	3.12e-08	652	58	13	int:RPL11
Interaction	H2BC5 interactions	NOLC1 H2BC1 RPL7L1 NEMF KMT2A PRMT3 SSB TOP2A IQGAP1 FGFBP1	3.24e-08	331	58	10	int:H2BC5
Interaction	NOP56 interactions	RPL22 NOLC1 DNAJC25 NEMF PUM3 SSB LYAR DDX24 TTF1 RPL6 TOP2A FGFBP1	6.36e-08	570	58	12	int:NOP56
Interaction	SRSF5 interactions	RPL7L1 KAT6A KMT2A PUM3 SSB USP39 LYAR DDX24 TTF1 RPL6 FGFBP1	9.12e-08	474	58	11	int:SRSF5
Interaction	DDX21 interactions	RPL22 RPL7L1 DNAJC25 APC PUM3 TAF15 SSB USP39 LYAR DDX24 RPL6 TOP2A FGFBP1	9.61e-08	718	58	13	int:DDX21
Interaction	RPL23A interactions	RPL22 NOLC1 RPL7L1 KAT6A NUFIP2 KMT2A PUM3 SSB LYAR DDX24 TTF1 RPL6	1.24e-07	606	58	12	int:RPL23A
Interaction	RPL5 interactions	RPL22 NOLC1 DNAJC25 KAT6A NEMF NUFIP2 PUM3 SSB LYAR DDX24 RPL6 FGFBP1	1.24e-07	606	58	12	int:RPL5
Interaction	ZC3H18 interactions	RPL22 NOLC1 RPL7L1 NUFIP2 PUM3 TAF15 SSB USP39 LYAR DDX24 RPL6 TOP2A IQGAP1 FGFBP1	1.34e-07	877	58	14	int:ZC3H18
Interaction	CHD3 interactions	RPL22 NOLC1 KAT6A KMT2A PUM3 TAF15 USP39 LYAR DDX24 RGS2 RPL6 TOP2A IQGAP1	1.77e-07	757	58	13	int:CHD3
Interaction	PRKRA interactions	RPL22 RPL7L1 KAT6A KMT2A PUM3 LYAR DDX24 TTF1 RPL6 FGFBP1	1.89e-07	400	58	10	int:PRKRA
Interaction	FBL interactions	NOLC1 UTP25 NUFIP2 PUM3 TAF15 PRMT3 SSB LYAR DDX24 FKBP3 RPL6 TOP2A	2.19e-07	639	58	12	int:FBL
Interaction	RPS24 interactions	RPL22 NOLC1 UTP25 KAT6A PUM3 CCDC168 SSB LYAR DDX24 RPL6 TOP2A	2.74e-07	529	58	11	int:RPS24
Interaction	RPS14 interactions	RPL22 NOLC1 RPL7L1 KAT6A PUM3 DDX24 TTF1 RPL6 TOP2A IQGAP1 FGFBP1	2.74e-07	529	58	11	int:RPS14
Interaction	RPL15 interactions	RPL22 NOLC1 RPL7L1 DNAJC25 KAT6A PUM3 LYAR DDX24 TTF1 RPL6 TOP2A	2.79e-07	530	58	11	int:RPL15
Interaction	CHD4 interactions	RPL22 NOLC1 H2BC1 KAT6A NUFIP2 KMT2A PUM3 TAF15 USP39 LYAR DDX24 RPL6 TOP2A IQGAP1	3.04e-07	938	58	14	int:CHD4
Interaction	RPLP0 interactions	RPL22 RPL7L1 DNAJC25 KAT6A KMT2A PUM3 SSB LYAR DDX24 TTF1 RPL6 IQGAP1	3.09e-07	660	58	12	int:RPLP0
Interaction	RPL8 interactions	RPL22 RPL7L1 DNAJC25 KAT6A NUFIP2 PUM3 DDX24 TTF1 RPL6 TOP2A FGFBP1	3.30e-07	539	58	11	int:RPL8
Interaction	RPL14 interactions	RPL22 RPL7L1 DNAJC25 KAT6A PUM3 SSB DDX24 TTF1 RPL6 TOP2A IQGAP1	4.33e-07	554	58	11	int:RPL14
Interaction	RPL13 interactions	RPL22 RPL7L1 KAT6A KMT2A PUM3 SSB LYAR DDX24 TTF1 RPL6 TOP2A FGFBP1	5.78e-07	700	58	12	int:RPL13
Interaction	RPL17 interactions	RPL22 RPL7L1 KAT6A PUM3 SSB LYAR DDX24 TTF1 RPL6 TOP2A FGFBP1	5.84e-07	571	58	11	int:RPL17
Interaction	RPS7 interactions	RPL22 NOLC1 KAT6A NEMF APC SSB DDX24 RPL6 TOP2A FGFBP1	7.67e-07	466	58	10	int:RPS7
Interaction	RBM4B interactions	RPL7L1 KAT6A APC PUM3 DDX24 TTF1 RPL6 TOP2A	8.01e-07	262	58	8	int:RBM4B
Interaction	RPL13A interactions	RPL22 RPL7L1 DNAJC25 KAT6A KMT2A PUM3 SSB LYAR DDX24 TTF1 RPL6	8.19e-07	591	58	11	int:RPL13A
Interaction	RPL30 interactions	RPL22 RPL7L1 KAT6A NEMF PUM3 LYAR DDX24 TTF1 RPL6 TOP2A	8.95e-07	474	58	10	int:RPL30
Interaction	RPS6 interactions	RPL22 NOLC1 RPL7L1 UTP25 KAT6A PUM3 SSB LYAR DDX24 TTF1 RPL6 TOP2A IQGAP1	9.05e-07	874	58	13	int:RPS6
Interaction	USP36 interactions	RPL22 NOLC1 RPL7L1 UTP25 PUM3 MARK2 LYAR DDX24 RPL6 TOP2A FGFBP1	9.35e-07	599	58	11	int:USP36
Interaction	SRPK1 interactions	KAT6A PUM3 TAF15 USP39 LYAR DDX24 FKBP3 TOP2A IQGAP1 FGFBP1	9.47e-07	477	58	10	int:SRPK1
Interaction	POLR1G interactions	NOLC1 KAT6A KMT2A PUM3 LYAR DDX24 TTF1 RPL6 TOP2A FGFBP1	1.19e-06	489	58	10	int:POLR1G
Interaction	SRPK3 interactions	RPL7L1 PUM3 USP39 LYAR DDX24 TTF1 TOP2A	1.19e-06	190	58	7	int:SRPK3
Interaction	RPL28 interactions	RPL22 RPL7L1 KAT6A PUM3 SIPA1L2 DDX24 TTF1 RPL6 TOP2A IQGAP1	1.30e-06	494	58	10	int:RPL28
Interaction	SRP68 interactions	RPL22 METTL18 NUFIP2 PUM3 SSB LYAR RPL6 TOP2A FGFBP1	1.32e-06	381	58	9	int:SRP68
Interaction	RPL36 interactions	RPL22 RPL7L1 KAT6A KMT2A PUM3 SSB DDX24 TTF1 RPL6 TOP2A	1.56e-06	504	58	10	int:RPL36
Interaction	RPL37A interactions	RPL22 RPL7L1 PUM3 LYAR EN1 DDX24 TTF1 RPL6 FGFBP1	1.63e-06	391	58	9	int:RPL37A
Interaction	RBM34 interactions	RPL7L1 KAT6A PUM3 SSB LYAR TTF1 RPL6 FGFBP1	1.71e-06	290	58	8	int:RBM34
Interaction	RPL19 interactions	RPL22 NOLC1 RPL7L1 KAT6A NEMF NUFIP2 SSB DDX24 FKBP3 RPL6 TOP2A	1.73e-06	638	58	11	int:RPL19
Interaction	RPL18 interactions	RPL22 DNAJC25 KAT6A PUM3 SSB LYAR DDX24 RPL6 TOP2A IQGAP1	1.79e-06	512	58	10	int:RPL18
Interaction	CIT interactions	RPL22 NOLC1 H2BC1 RPL7L1 DSG2 NUFIP2 KMT2A PUM3 TAF15 ABCG2 SSB USP39 LYAR RPL6 TOP2A IQGAP1	2.10e-06	1450	58	16	int:CIT
Interaction	BRIX1 interactions	RPL22 NOLC1 KAT6A PUM3 LYAR DDX24 RPL6 FGFBP1	2.21e-06	300	58	8	int:BRIX1
Interaction	RPS3A interactions	RPL22 H2BC1 RPL7L1 KAT6A PUM3 SSB LYAR DDX24 TTF1 RPL6 TOP2A	2.23e-06	655	58	11	int:RPS3A
Interaction	H1-4 interactions	RPL22 NOLC1 RPL7L1 KMT2A PUM3 PRMT3 SSB DDX24 TTF1 RPL6 WDR44	2.26e-06	656	58	11	int:H1-4
Interaction	DDX56 interactions	NOLC1 RPL7L1 KAT6A NUFIP2 PUM3 LYAR DDX24 FGFBP1	2.44e-06	304	58	8	int:DDX56
Interaction	CSNK2A1 interactions	RPL22 NOLC1 RPL7L1 KAT6A APC KMT2A SSB EN1 DDX24 FKBP3 RPL6 TOP2A WDR44	2.45e-06	956	58	13	int:CSNK2A1
Interaction	RPS4X interactions	RPL22 NOLC1 H2BC1 KAT6A SSB DDX24 RPL6 TOP2A IQGAP1 FGFBP1	2.88e-06	540	58	10	int:RPS4X
Interaction	PRC1 interactions	RPL22 NOLC1 H2BC1 RPL7L1 DSG2 APC PUM3 TAF15 USP39 LYAR RPL6 TOP2A IQGAP1	2.98e-06	973	58	13	int:PRC1
Interaction	FTSJ3 interactions	RPL22 UTP25 KAT6A APC PUM3 LYAR DDX24 RPL6 FGFBP1	3.05e-06	422	58	9	int:FTSJ3
Interaction	RPL31 interactions	RPL22 NOLC1 RPL7L1 KAT6A PUM3 SSB LYAR DDX24 TTF1 RPL6 TOP2A	3.20e-06	680	58	11	int:RPL31
Interaction	OASL interactions	RPL7L1 KMT2A PUM3 SSB LYAR DDX24 TTF1	3.44e-06	223	58	7	int:OASL
Interaction	NIFK interactions	NOLC1 RPL7L1 KAT6A PUM3 SSB LYAR DDX24 TTF1 FGFBP1	3.62e-06	431	58	9	int:NIFK
Interaction	H1-6 interactions	H2BC1 UTP25 PUM3 LYAR TTF1 RPL6 FGFBP1	4.10e-06	229	58	7	int:H1-6
Interaction	ZNF48 interactions	RPL22 RPL7L1 PUM3 DDX24 TTF1 FGFBP1	4.35e-06	149	58	6	int:ZNF48
Interaction	DDX27 interactions	RPL22 RPL7L1 KAT6A PUM3 SSB LYAR DDX24 FGFBP1	4.37e-06	329	58	8	int:DDX27
Interaction	SRP72 interactions	RPL22 METTL18 NUFIP2 SSB LYAR RPL6 TOP2A FGFBP1	4.77e-06	333	58	8	int:SRP72
Interaction	ZNF330 interactions	RPL22 NOLC1 KMT2A PUM3 SSB LYAR DDX24 RPL6 TOP2A	4.78e-06	446	58	9	int:ZNF330
Interaction	RNF2 interactions	RPL22 NOLC1 RPL7L1 KMT2A PUM3 TAF15 SSB LYAR DDX24 RPL6 TOP2A IQGAP1	5.28e-06	866	58	12	int:RNF2
Interaction	MEN1 interactions	NOLC1 RPL7L1 NUFIP2 KMT2A PUM3 TAF15 SSB USP39 LYAR DDX24 RPL6 TOP2A IQGAP1	5.49e-06	1029	58	13	int:MEN1
Interaction	KIF23 interactions	RPL22 NOLC1 H2BC1 DSG2 NUFIP2 APC PUM3 ABCG2 SSB LYAR RPL6 TOP2A IQGAP1	5.61e-06	1031	58	13	int:KIF23
Interaction	CTCF interactions	RPL22 KAT6A PUM3 LYAR EN1 RPL6 TOP2A IQGAP1 FGFBP1	6.25e-06	461	58	9	int:CTCF
Interaction	SRP14 interactions	RPL22 NOLC1 METTL18 PUM3 LYAR DDX24 TTF1 RPL6	9.52e-06	366	58	8	int:SRP14
Interaction	REXO4 interactions	RPL7L1 KAT6A PUM3 LYAR DDX24 TTF1 FGFBP1	9.65e-06	261	58	7	int:REXO4
Interaction	ADARB1 interactions	RPL22 RPL7L1 PUM3 USP39 LYAR DDX24 TTF1 RPL6 TOP2A	1.00e-05	489	58	9	int:ADARB1
Interaction	RPL10A interactions	RPL22 DNAJC25 PUM3 SSB LYAR DDX24 TTF1 RPL6 TOP2A	1.02e-05	490	58	9	int:RPL10A
Interaction	CSNK2B interactions	NOLC1 HTRA1 KAT6A APC KMT2A SSB DDX24 FKBP3 TOP2A IQGAP1	1.04e-05	625	58	10	int:CSNK2B
Interaction	KRR1 interactions	RPL7L1 KMT2A PUM3 SSB DDX24 TTF1 RPL6 FGFBP1	1.23e-05	379	58	8	int:KRR1
Interaction	H1-1 interactions	RPL7L1 PUM3 SSB LYAR DDX24 TTF1 RPL6 IQGAP1 FGFBP1	1.34e-05	507	58	9	int:H1-1
Interaction	FBXO32 interactions	RPL22 MYH8 TAF15 SSB LYAR DDX24 RPL6 TOP2A	1.40e-05	386	58	8	int:FBXO32
Interaction	GRWD1 interactions	RPL22 METTL18 KAT6A KMT2A DDX24 RPL6 TOP2A IQGAP1	1.51e-05	390	58	8	int:GRWD1
Interaction	RPS9 interactions	RPL22 RPL7L1 KAT6A KMT2A LYAR DDX24 RPL6 TOP2A IQGAP1	1.52e-05	515	58	9	int:RPS9
Interaction	RPS2 interactions	RPL22 RPL7L1 KAT6A PRMT3 SSB DDX24 TTF1 RPL6 TOP2A FGFBP1	1.61e-05	657	58	10	int:RPS2
Interaction	RSL24D1 interactions	RPL22 RPL7L1 KAT6A LYAR FGFBP1	1.61e-05	110	58	5	int:RSL24D1
Interaction	DOT1L interactions	RPL7L1 DSG2 KMT2A PUM3 TAF15 SSB USP39 LYAR DDX24 RPL6 TOP2A	1.61e-05	807	58	11	int:DOT1L
Interaction	RPLP2 interactions	RPL22 DNAJC25 KAT6A SSB LYAR DDX24 RPL6 TOP2A	2.12e-05	409	58	8	int:RPLP2
Interaction	RPL7A interactions	RPL22 NOLC1 RPL7L1 DNAJC25 KAT6A PUM3 SSB DDX24 TTF1 RPL6	2.13e-05	679	58	10	int:RPL7A
Interaction	SSRP1 interactions	NOLC1 H2BC1 KAT6A KMT2A TAF15 SSB USP39 LYAR TOP2A FGFBP1	2.30e-05	685	58	10	int:SSRP1
Interaction	SNRPD2 interactions	RPL22 METTL18 TAF15 SSB USP39 EN1 TOP2A IQGAP1	2.31e-05	414	58	8	int:SNRPD2
Interaction	CCDC137 interactions	RPL7L1 KAT6A PUM3 LYAR TTF1 FGFBP1	2.33e-05	200	58	6	int:CCDC137
Interaction	RNF113A interactions	RPL22 NOLC1 NUFIP2 PUM3 TAF15 SSB LYAR DDX24 RPL6 IQGAP1	2.51e-05	692	58	10	int:RNF113A
Interaction	TOP1 interactions	RPL22 KAT6A NUFIP2 KMT2A TAF15 USP39 DDX24 RPL6 TOP2A FGFBP1	2.64e-05	696	58	10	int:TOP1
Interaction	ABT1 interactions	RPL7L1 UTP25 KMT2A PUM3 LYAR DDX24 TTF1 FGFBP1	2.70e-05	423	58	8	int:ABT1
Interaction	RPS27L interactions	RPL22 KAT6A SSB C3orf20 RPL6 TOP2A	2.76e-05	206	58	6	int:RPS27L
Interaction	SURF6 interactions	RPL22 RPL7L1 PUM3 LYAR DDX24 TTF1 RPL6 FGFBP1	2.84e-05	426	58	8	int:SURF6
Interaction	RPL10 interactions	RPL22 RPL7L1 KAT6A NEMF NUFIP2 PUM3 LYAR DDX24 RPL6 TOP2A	2.84e-05	702	58	10	int:RPL10
Interaction	NPM1 interactions	RPL22 RPL7L1 DNAJC25 KAT6A NUFIP2 KMT2A PUM3 SSB LYAR DDX24 TTF1 RPL6 TOP2A	2.86e-05	1201	58	13	int:NPM1
Interaction	RPL26L1 interactions	RPL22 RPL7L1 KAT6A PUM3 LYAR DDX24 RPL6 FGFBP1	3.08e-05	431	58	8	int:RPL26L1
Interaction	HNRNPU interactions	RPL22 H2BC1 KAT6A PUM3 TAF15 USP39 LYAR DDX24 FKBP3 RPL6 TOP2A IQGAP1	3.15e-05	1035	58	12	int:HNRNPU
Interaction	IFI16 interactions	NEMF NUFIP2 PUM3 SSB USP39 MARK2 LYAR DDX24 RPL6 TOP2A	3.28e-05	714	58	10	int:IFI16
Interaction	PRR11 interactions	RPL7L1 PUM3 LYAR DDX24 TTF1	3.60e-05	130	58	5	int:PRR11
Interaction	KIF20A interactions	RPL22 NOLC1 H2BC1 RPL7L1 DSG2 NUFIP2 PUM3 TAF15 ABCG2 LYAR RPL6 TOP2A	3.69e-05	1052	58	12	int:KIF20A
Interaction	THOC5 interactions	RPL22 NEMF TAF15 DDX24 RPL6	3.74e-05	131	58	5	int:THOC5
Interaction	GTPBP4 interactions	RPL22 RPL7L1 PUM3 LYAR EN1 DDX24 RPL6 FGFBP1	3.75e-05	443	58	8	int:GTPBP4
Interaction	MAGEB10 interactions	RPL7L1 PUM3 LYAR RPL6	3.90e-05	66	58	4	int:MAGEB10
Interaction	RPL18A interactions	RPL22 NOLC1 KAT6A PUM3 LYAR DDX24 TTF1 RPL6	3.99e-05	447	58	8	int:RPL18A
Interaction	ATG4B interactions	RPL22 KAT6A NUFIP2 RPL6 TOP2A	4.16e-05	134	58	5	int:ATG4B
Interaction	ZBTB2 interactions	NOLC1 RPL7L1 KAT6A LYAR DDX24 FKBP3 RPL6 TOP2A	4.18e-05	450	58	8	int:ZBTB2
Interaction	DDRGK1 interactions	RPL22 RPL7L1 NOX5 DNAJC25 NEMF PUM3 SSB USP39 MARK2 LYAR DDX24 RPL6 TOP2A	4.30e-05	1249	58	13	int:DDRGK1
Interaction	OBSL1 interactions	NOLC1 RPL7L1 DSG2 NEMF PUM3 TAF15 USP39 SIPA1L2 RPL6 TOP2A IQGAP1	4.49e-05	902	58	11	int:OBSL1
Interaction	MYBBP1A interactions	RPL7L1 UTP25 PUM3 LYAR DDX24 TTF1 RPL6 FGFBP1	5.11e-05	463	58	8	int:MYBBP1A
GeneFamily	L ribosomal proteins	RPL22 RPL7L1 RPL6	2.25e-04	51	42	3	729
GeneFamily	Myosin heavy chains	MYH2 MYH8	5.43e-04	15	42	2	1098
GeneFamily	Zinc fingers C2HC-type\|PHD finger proteins\|Lysine acetyltransferases	KAT6A LYAR	6.19e-04	16	42	2	66
GeneFamily	UDP glucuronosyltransferases	UGT2A1 UGT2A2	2.50e-03	32	42	2	363
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	APC ARMCX4	4.48e-03	43	42	2	409
Coexpression	GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP	NOLC1 RPL7L1 KMT2A PRMT3 SIPA1L2 RPL6	5.89e-06	200	59	6	M5819
Coexpression	MARSON_FOXP3_TARGETS_DN	NOLC1 SLFN12L UTP25 RGS2	1.03e-05	60	59	4	MM847
Coexpression	LEE_BMP2_TARGETS_DN	NOLC1 RPL7L1 UTP25 PUM3 PRMT3 SSB TNFAIP2 USP39 LYAR FKBP3	3.07e-05	904	59	10	M2325
Coexpression	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	NOLC1 PUM3 PRMT3 SSB ITPA	3.15e-05	161	59	5	M5075
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	TRIO DSG2 NEMF APC PUM3 SSB LYAR TOP2A IQGAP1	3.15e-05	721	59	9	M10237
Coexpression	LEE_BMP2_TARGETS_DN	NOLC1 RPL7L1 UTP25 PUM3 PRMT3 SSB TNFAIP2 USP39 LYAR FKBP3	3.63e-05	922	59	10	MM1068
Coexpression	JOHNSTONE_PARVB_TARGETS_3_UP	MGAT4B HTRA1 TRIO KMT2A ABCG2 TNFAIP2 IQGAP1	5.20e-05	433	59	7	M2240
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	HTRA1 APC TNFAIP2 EN1 RGS2	7.82e-05	195	59	5	M1110
Coexpression	GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_UP	MYH2 SLFN12L KMT2A IREB2 EN1	8.41e-05	198	59	5	M7050
Coexpression	GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN	HTRA1 KMT2A SSB TNFAIP2 RGS2	8.61e-05	199	59	5	M5242
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	HTRA1 APC TNFAIP2 EN1 RGS2	1.04e-04	207	59	5	MM475
Coexpression	VISALA_AGING_LYMPHOCYTE_UP	KAT6A TAF15	1.04e-04	7	59	2	M2050
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	NOLC1 DZANK1 DNAJC25 NEMF APC TAF15 SSB USP39 LYAR CCDC77 TTF1 FKBP3 TOP2A TGM5	4.21e-06	1257	57	14	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	RPL22 NOLC1 DZANK1 DNAJC25 NEMF APC TAF15 SSB LYAR FKBP3 RPL6 TOP2A TGM5	1.91e-05	1241	57	13	facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	NOLC1 DZANK1 DNAJC25 NEMF APC TAF15 SSB USP39 LYAR CCDC77 TTF1 FKBP3 TOP2A TGM5	2.29e-05	1459	57	14	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_500	MYH2 GRHL1 MYH8 DSG2 TNFAIP2 RGS2 FGFBP1	7.27e-05	384	57	7	gudmap_developingLowerUrinaryTract_P1_bladder_500_B
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500	RPL22 NOLC1 DZANK1 DNAJC25 NEMF APC TAF15 SSB LYAR FKBP3 RPL6 TOP2A TGM5	1.09e-04	1468	57	13	facebase_RNAseq_e10.5_MandArch_2500
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	NEMF PUM3 ANKRD12 LYAR TTF1 TOP2A	2.43e-07	197	59	6	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	E17.5\|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RPL22 RGS2 RPL6 IQGAP1 FGFBP1	2.99e-06	169	59	5	56aa58636ec624819ca88c8c27a7493c3f8c49fc
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KAT6A NUFIP2 APC KMT2A IQGAP1	4.53e-06	184	59	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	5'-Adult-Appendix\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RPL22 NOLC1 PUM3 TNFAIP2 RPL6	6.17e-06	196	59	5	a579211ef14f348d0c5a290553150222dfbf1515
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SLFN12L KMT2A ANKRD12 DDX24 C3orf20	6.32e-06	197	59	5	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	moderate-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SLFN12L KMT2A ANKRD12 DDX24 IQGAP1	6.48e-06	198	59	5	0a868098b1ee4b28b2149ed766acb09e9c0ce14c
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	SLFN12L KAT6A ANKRD12 DDX24	7.79e-05	171	59	4	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP3 TNFAIP2 RGS2 IQGAP1	7.97e-05	172	59	4	3f784aed340b50ddbec3f7dc0a5279180d38a2bb
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-7\|TCGA-Breast / Sample_Type by Project: Shred V9	PUM3 LYAR CCDC77 EN1	7.97e-05	172	59	4	a2c3b790be85f7fd23f2dc919dcc749656920e71
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKRD12 SSB TNFAIP2 DDX24	1.10e-04	187	59	4	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	facs-Thymus-Flowthrough-24m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPL22 FKBP3 RPL6 TOP2A	1.10e-04	187	59	4	376a95ac1e38f61f8db5d23d9a905f8dae8c40b6
ToppCell	(02)_Cycling_Basal_(regeneration)-(1)_24hpi\|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint	NOLC1 LYAR TOP2A FGFBP1	1.15e-04	189	59	4	311f3aed469be3c8ff913dcc5a2442daa8446d55
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOLC1 PUM3 PRMT3 RPL6	1.17e-04	190	59	4	52c59001a079c76249abbaa3141e9e661b83d9a0
ToppCell	11.5-Distal\|11.5 / Age, Tissue, Lineage and Cell class	RPL22 HTRA1 RGS2 RPL6	1.22e-04	192	59	4	169b9ee2377beb9e4ad35bc82bb7a3dafe8f05b6
ToppCell	droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5+_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPL22 NOLC1 RPL6 TOP2A	1.22e-04	192	59	4	5155f746ad57122ef735da776c96721005b8dadc
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SLFN12L ANKRD12 DDX24 C3orf20	1.24e-04	193	59	4	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	droplet-Tongue-nan-3m-Epithelial-suprabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRHL1 RGS2 TGM5 FGFBP1	1.24e-04	193	59	4	a7002acf3be76b2cc6fc9364176f6b0d3bd27d9c
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-suprabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRHL1 ANKRD12 TGM5 FGFBP1	1.27e-04	194	59	4	a3adcdc8b87332e8beb9bcd70cf36424af10633d
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SLFN12L KAT6A KMT2A ANKRD12	1.29e-04	195	59	4	4bdedd924564a260841a9153604026b57487c83d
ToppCell	Multiple_Sclerosis-Lymphocyte-T_NK-CD4_TCM\|Multiple_Sclerosis / Disease, Lineage and Cell Type	RPL22 ANKRD12 DDX24 RPL6	1.32e-04	196	59	4	30c31f3d2c1fb3667c5c7f2057eca067dcd69e4d
ToppCell	control-Others-CD34+_GATA2+_cells\|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	RPL22 RPL7L1 SSB RPL6	1.32e-04	196	59	4	25994ca143701c72d2f84a3b6d348fcfa1d26a54
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RPL22 SLFN12L KMT2A SSB	1.32e-04	196	59	4	c9fb81a0578db6d278b8582d7b3add6c407e6dcf
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRIO SSB LYAR ITPA	1.34e-04	197	59	4	7293587c875738c1711b8a68d40303a197b01c32
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRIO DSG2 EN1 TOP2A	1.34e-04	197	59	4	196eaecef7003ed83f323c1f157c6a3594650097
ToppCell	mild-Treg\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SLFN12L KMT2A ANKRD12 DDX24	1.34e-04	197	59	4	39800e6e83f2d333b753d121c7aeb2912b91faa2
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_2\|COVID-19_Mild / Disease condition and Cell class	RPL22 TNFAIP2 RGS2 RPL6	1.34e-04	197	59	4	e844f660010d114d65bd814f3d3fccd8e4a6b8da
ToppCell	BL-critical-LOC-Lymphoid\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RPL22 SLFN12L KMT2A DDX24	1.37e-04	198	59	4	1c0227e58a64c0bf509bfb9578fb91277316b120
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_2\|Classical_Monocyte / Disease condition and Cell class	RPL22 TNFAIP2 RGS2 RPL6	1.37e-04	198	59	4	ec237326b7f554b49af5d78f39f339d1fca2bc54
ToppCell	HSPCs\|World / Lineage and Cell class	RPL22 NOLC1 LYAR FKBP3	1.40e-04	199	59	4	df1ffc416c6946f1ba182f242a50ee41a571d565
ToppCell	mild-CD4+_Tcm\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SLFN12L KMT2A ANKRD12 DDX24	1.40e-04	199	59	4	06c8a0e39f7a33736548f04a5e2263334c8541cf
ToppCell	mild-CD4+_T_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SLFN12L KMT2A ANKRD12 DDX24	1.40e-04	199	59	4	3e4baaf4ee23f257d821194468102c00a8ad2f21
ToppCell	mild-MAIT\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SLFN12L ABCG2 LYAR DDX24	1.40e-04	199	59	4	cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84
ToppCell	NS-critical-LOC-Lymphoid\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RPL22 KMT2A DDX24 RPL6	1.40e-04	199	59	4	e2d0346cc0c45253b1f958e11263f45e09fd38cb
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_2\|Classical_Monocyte / Disease condition and Cell class	RPL22 TNFAIP2 RGS2 IQGAP1	1.40e-04	199	59	4	3feee9f53860b4b2e93ff2360beb2b2b74f51d24
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SLFN12L KMT2A LYAR DDX24	1.42e-04	200	59	4	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	Sepsis-URO-Lymphocyte-T/NK-CD4+_Tem\|URO / Disease, condition lineage and cell class	CCDC168 ABCG2 LYAR RPL6	1.42e-04	200	59	4	8b7bfe6411de9528603481f6e5612cbbb8471cf6
ToppCell	PBMC-Severe-Lymphocyte-T/NK\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	SLFN12L ANKRD12 DDX24 RPL6	1.42e-04	200	59	4	73b91cb66c375b44e852404a4a445cf2b9595aee
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RPL22 KMT2A DDX24 RPL6	1.42e-04	200	59	4	b340b6acf675c75adffb98e560080f966571f594
ToppCell	MS-IIF-Lymphocyte-T/NK\|IIF / Disease, condition lineage and cell class	RPL22 LYAR DDX24 RPL6	1.42e-04	200	59	4	403e956d5a770811298694081b55e47e4ca2d814
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NUFIP2 KMT2A ANKRD12 DDX24	1.42e-04	200	59	4	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	COVID-19_Severe-Lymphoid_T/NK\|COVID-19_Severe / Disease group, lineage and cell class	SLFN12L ANKRD12 DDX24 RPL6	1.42e-04	200	59	4	9fc818bf5c9133fc2fece47980e71fd3f8603558
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SLFN12L KMT2A LYAR DDX24	1.42e-04	200	59	4	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	MS-Multiple_Sclerosis-Lymphocyte-T/NK-CD4+_Tcm\|Multiple_Sclerosis / Disease, condition lineage and cell class	RPL22 ANKRD12 DDX24 RPL6	1.42e-04	200	59	4	33546f8d533c7e7ebd29b917b868352fb5bf24a9
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	RPL22 LYAR DDX24 RPL6	1.42e-04	200	59	4	87d0240328d1c4f0aa052c2dc96155c884ee514b
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	KMT2A ANKRD12 DDX24 IQGAP1	1.42e-04	200	59	4	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	PBMC-Severe-Lymphocyte-T/NK\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SLFN12L ANKRD12 DDX24 RPL6	1.42e-04	200	59	4	f1c8780d64b58b6fb84fffbc27f0ad337b1a6e56
Computational	Neighborhood of NPM1	NOLC1 PUM3 SSB RPL6	1.15e-04	72	38	4	GNF2_NPM1
Disease	Abnormality of the sense of smell, COVID-19 symptoms measurement, ageusia	UGT2A1 UGT2A2	3.29e-06	2	54	2	EFO_0600019, EFO_1001758, HP_0004408
Disease	Adenoid Cystic Carcinoma	KAT6A MARK2 EN1 TOP2A	3.45e-05	100	54	4	C0010606
Disease	Malignant neoplasm of salivary gland	MARK2 EN1 TOP2A	7.79e-05	45	54	3	C0220636
Disease	Salivary Gland Neoplasms	MARK2 EN1 TOP2A	8.87e-05	47	54	3	C0036095
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH2 MYH8	1.47e-04	10	54	2	DOID:0110454 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH2 MYH8	1.47e-04	10	54	2	DOID:0111269 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH2 MYH8	1.47e-04	10	54	2	DOID:0080719 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH2 MYH8	1.47e-04	10	54	2	DOID:0111602 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH2 MYH8	1.47e-04	10	54	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH2 MYH8	1.47e-04	10	54	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH2 MYH8	1.47e-04	10	54	2	DOID:0080326 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH2 MYH8	1.47e-04	10	54	2	DOID:0111596 (implicated_via_orthology)
Disease	Ck-beta-8-1 measurement	SLFN12L TAF15	2.14e-04	12	54	2	EFO_0008085
Disease	distal myopathy (implicated_via_orthology)	MYH2 MYH8	2.14e-04	12	54	2	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH2 MYH8	2.14e-04	12	54	2	DOID:2106 (implicated_via_orthology)
Disease	paraxanthine measurement	NOX5 ABCG2	2.14e-04	12	54	2	EFO_0021178
Disease	acute myeloid leukemia (implicated_via_orthology)	KMT2A TOP2A	2.14e-04	12	54	2	DOID:9119 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH2 MYH8	2.53e-04	13	54	2	DOID:397 (implicated_via_orthology)
Disease	anemia (implicated_via_orthology)	APC IREB2	3.40e-04	15	54	2	DOID:2355 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH2 MYH8	3.40e-04	15	54	2	DOID:0050646 (implicated_via_orthology)
Disease	Neurodevelopmental Disorders	HIVEP3 TRIO KMT2A	6.69e-04	93	54	3	C1535926
Disease	Acute Myeloid Leukemia, M1	TRIO KMT2A RGS2	1.57e-03	125	54	3	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	TRIO KMT2A RGS2	1.57e-03	125	54	3	C1879321

Protein segments in the cluster

Peptide	Gene	Start	Entry
GVAIKFGKFSVKENK	TTF1	531	Q15361
VEGKKKVKNGLHSKV	FGFBP1	21	Q14512
QLSGGEKKKKITVFK	ABCG2	351	Q9UNQ0
KIQGELKNLKSKVFG	CCDC77	466	Q9BR77
VVSGEHKQKGKVKRK	ANKRD12	461	Q6UB98
GKIVKKEAVTQTKAK	ARMCX4	156	Q5H9R4
INKQKGGLKALSKEK	IQGAP1	951	P46940
GEFFKQIGIIKTNKK	TAF15	251	Q92804
SKSAVKKKPQKVAGG	NOLC1	486	Q14978
KVGFKGFQIAAEKQK	IREB2	471	P48200
SITKLGKKGVKQFKN	PUM3	56	Q15397
SKVFQKVAAEKKGKV	NOX5	721	Q96PH1
KVKVKNVKEGIHFKS	DSG2	376	Q14126
GKGKVQFQGKKTKFA	SSB	351	P05455
YKVKLTPGVQKKGKA	NEMF	1011	O60524
AGKIQKLKDKDFGKQ	MGAT4B	376	Q9UQ53
GKSANFQKPKVVKGK	MYH8	561	P13535
GKSANFQKPKVVKGK	MYH2	561	Q9UKX2
KAKVKFAGKKVLDLG	METTL18	181	O95568
RNKEVKSAFKKTVGK	OR5B12	291	Q96R08
KSAFKKTVGKAKASI	OR5B12	296	Q96R08
FQNKRAKIKKATGIK	EN1	351	Q05925
KFNKKTKGLIDGLTK	KAT6A	401	Q92794
IAKQQGLLKKAKEKG	DNAJC25	191	Q9H1X3
SKGATISKKGFKKAV	H2BC1	6	Q96A08
QAKGKAITKKKYIGI	HTRA1	371	Q92743
IGKIFKKCKKGILVN	GRHL1	571	Q9NZI5
GEALKGKVTVHKNKK	PRMT3	496	O60678
FSLSAGKEAKKKIGK	C3orf20	236	Q8ND61
KKNAKPLSFKVGVGK	FKBP3	156	Q00688
KGKFNWKGTIKAILK	LYAR	306	Q9NX58
LKTIGKGNFAKVKLA	MARK2	56	Q7KZI7
GKFQTKGIKVVGKWK	DDX24	16	Q9GZR7
VGKKIVFVTGNAKKL	ITPA	6	Q9BY32
LKSKFKTGKLQIGRK	KMT2A	281	Q03164
LDFKTKFKKINQTKG	CCDC168	1391	Q8NDH2
QEFKNGFVGSKLKKK	DZANK1	126	Q9NVP4
KKKIIVSNKKRFQGE	UTP25	381	Q68CQ4
GKPKTGKKSKQQAFI	RGS2	56	P41220
GTKKKKKTIVTDVFQ	USP39	336	Q53GS9
KQALLAKKEQKKGKG	RPL7L1	41	Q6DKI1
VKFSFITLGAKKKEK	SIPA1L2	826	Q9P2F8
QKAFLAGKFKVSGKV	SCP2D1	126	Q9UJQ7
KGIKGGKKVYKSLIT	APC	2186	P25054
KEAVKELGQKRFKGK	TPPP2	71	P59282
ATVIKKSNQKGKAKG	TULP1	256	O00294
ANVFCVFTKGKKKKG	TNFAIP2	41	Q03169
KQTVKANTFGKAGIK	NUFIP2	136	Q7Z417
VDAGGKVKKGNLKAK	RPL6	21	Q02878
LKQKLAKIGGYTKKV	SLFN12L	496	Q6IEE8
KTKKGLKTKGVIYEC	HIVEP3	631	Q5T1R4
TQLKKFLGKSVKRAK	WDR44	426	Q5JSH3
GGKKKKQVLKFTLDC	RPL22	11	P35268
AEVKEKGKKGKAVHF	PPP1R36	66	Q96LQ0
GLFKKQQKVFLGVLK	TGM5	661	O43548
VKKKNKGGVAVKAHQ	TOP2A	341	P11388
LFSCQKFGKIGKKKK	UGT2A1	511	P0DTE4
KGNVVKFSAGKVKLK	ZBBX	86	A8MT70
KGTKRAVATKFVNKK	TRIO	2816	O75962
FSCQKFGKIGKKKKR	UGT2A2	521	P0DTE5